AllianceBernstein
DSCI

AllianceBernstein’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

AllianceBernstein’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,000
Closed -$8K – 3581
2015
Q1 		$8K Hold
1,000
– – ﹤0.01% 3382
2014
Q4 		$9K Sell
1,000
-100
-9% -$869 ﹤0.01% 3324
2014
Q3 		$9K Sell
1,100
-900
-45% -$8.34K ﹤0.01% 3306
2014
Q2 		$23K Buy
2,000
+1,464
+273% +$15K ﹤0.01% 3221
2014
Q1 		$7K Buy
536
+236
+79% +$3.05K ﹤0.01% 3321
2013
Q4 		$3K Sell
300
-600
-67% -$6.97K ﹤0.01% 3208
2013
Q3 		$11K Sell
900
-182
-17% -$2.52K ﹤0.01% 3155
2013
Q2 		$14K Buy
+1,082
New +$13.9K ﹤0.01% 3106

Other funds holding DSCI

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein's DSCI Position: Q2 2015 in Review

AllianceBernstein sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 1,000 shares — an estimated $8K sold.

AllianceBernstein first reported a position in DSCI in Q2 2013 and held it in 8 quarters. The position peaked at $23K in Q2 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

  • AllianceBernstein reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 1,000 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $8K.
  • AllianceBernstein first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 8 quarters.
  • AllianceBernstein's Derma Sciences, Inc. Common Stock (DE) position peaked at $23K in Q2 2014.
  • 62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.